• Joao Seda Neto, Eduardo Carone, Vincenzo Pugliese, Alcides Salzedas, Eduardo A Fonseca, Hsiang Teng, Gilda Porta, Renata Pugliese, Irene Miura, Vera Baggio, Massami Hayashi, Marcos Beloto, Teresa Guimaraes, Andre Godoy, Mario Kondo, and Paulo Chapchap.
• Hospital do Cancer, Hospital Sirio-Libanes, São Paulo, SP, Brazil.
• Liver Transpl. 2007 Aug 1; 13 (8): 1153-8.

AbstractInfants with end-stage liver disease represent a treatment challenge. Living donor liver transplantation (LDLT) is the only option for timely liver transplantation in many areas of the world, adding to the technical difficulties of the procedure. Factors that affect morbidity and mortality can now be determined, which opens a new era for improvement. We have accumulated an 11-year experience with LDLT for children weighing<10 kg. From October 1995 to October 2006, a total of 222 LDLT in patients<18 years of age were performed; 129 primary LDLT and 7 retransplants (4 LDLT and 3 deceased donor grafts) were performed in 129 infants weighing<10 kg. Forty-seven patients received grafts with graft-to-recipient weight ratio (GRWR) of >4%. Two patients received monosegmental grafts, and 2 patients underwent delayed abdominal wall closure. Portal vein thrombosis occurred in 5.4% of the patients, hepatic artery thrombosis in 3.1%, and both in 1.5%. Among several variables studied, only the bilirubin level at the time of transplantation was associated with increased risk of death (P=0.009). Grafts with GRWR>4% had no negative effect on patient survival. There were 7 retransplants, and 4 patients received a second parental LDLT. Patient survival rates at 1, 3, and 10 years after transplantation were 88.8%, 84.7%, and 82% for all children, and 87.5%, 84.9%, and 84.9% for infants weighing<10 kg. LDLT has results comparable to other modalities of liver transplantation in infants. Monosegment grafts were rarely required in this series, although they may be necessary in patients with lower body weight.Copyright (c) 2007 AASLD.

25 keywords...

hide…